MDM2 SNP309 accelerates colorectal tumour formation in women. - Wikidata - wikimedia - TriplyDB

MDM2 SNP309 accelerates colorectal tumour formation in women.

MDM2 SNP309 accelerates colorectal tumour formation in women.

http://www.wikidata.org/entity/Q43146294

about

Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck An information-theoretic analysis of genetics, gender and age in cancer patients Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians Germline mutations and polymorphisms in the origins of cancers in women.Single-nucleotide polymorphisms in the p53 signaling pathway.MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk.p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors.Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.The MDM2 gene family.The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls.Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer.MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk.Haplotype structure and selection of the MDM2 oncogene in humans.MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.Identification of functional DNA variants in the constitutive promoter region of MDM2 Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans.Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson.MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.Characterization of cancer-associated missense mutations in MDM2.MDM2 expression and regulation in prostate cancer racial disparity Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer.No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes.MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer.Molecular mechanisms involving prostate cancer racial disparity.Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients.Meta-analysis of associations between MDM2 SNP309 polymorphism and gastric cancer risk.MDM2 SNP309 polymorphism is associated with colorectal cancer risk.An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?Molecular basis for prostate cancer racial disparities.No association between MDM2 SNP309 promoter polymorphism and basal cell carcinoma of the skin.Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.Molecular mechanisms involving prostate cancer racial disparity.Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon.

P2860

Q24630090-EF9B7418-668C-4F13-8D46-B639F5A5C433 Q33327370-9781B0C4-5C57-4693-97C2-CA649D7011AE Q33330479-E0D151A9-4C78-4AEA-9440-E570D8F77977 Q33330490-2C19238E-D799-4C86-ACA6-E6E0587FBA4E Q33606675-500ED53F-BBDA-4A30-AF97-8D87D894B01F Q33800384-2D00BA63-72E9-428A-BE5B-A898E65D4FCA Q34257381-E82D0175-05E5-4794-959C-029F23181E0E Q34432427-B121D94F-BFC2-498A-A4C7-951897457BC6 Q34435034-EC033702-6BAA-4554-8E40-C2CCC53DF99B Q34460686-9936024A-4CC1-43B6-ABF6-36D8885A4142 Q34575963-7B011A2A-6BF4-4659-A50F-94CA3DF35EA1 Q34968358-9EBBFD29-B13A-4273-B2CA-A3C347281746 Q35010195-F056AAE9-C48A-4F42-AF81-65FEAC277759 Q35240086-E8669671-1715-4D1B-9FB6-C10218B1275A Q35679374-9C3BD847-3186-4045-916C-A32BC036A1B8 Q35693755-47B0C902-300C-40B5-B341-C15E1D10F6A8 Q35721519-D7D36C48-FE23-4075-ABE1-438C5734B820 Q36150107-466776D1-EF5F-41B4-8F52-3066FC4E3BA1 Q36405382-EBB8EE7D-5B35-41C4-9B11-AC836413738F Q36724434-ADB3A871-EEA1-456B-BF04-BDAEB6CAFE73 Q36745377-26ED9184-768E-4322-B6A7-7E5214C916BD Q36777343-0A7865BE-3B1A-427F-8313-C6CFC9C8DCA3 Q36787577-0387EA85-60F7-48D8-9267-CCFD9A93272A Q36998050-D1244D7B-2F8F-4C4A-B10C-A79DD07C357A Q37041767-44EE7963-F01B-4A21-B6ED-D909552F64A0 Q37112360-078FDFF0-E763-434C-B8AF-0F07C2BFC2C8 Q37195909-E3FACE9F-4FD5-44EE-A43B-4707018500B9 Q37254339-372C15B8-05EA-4E64-AED6-4C61B1CF6907 Q37418937-72805B99-348E-4104-A4A3-AF39C51D69B9 Q37499251-9EC48C6F-2C3A-4CCC-97C9-19F1069664E0 Q37565358-BA9012F3-B624-4ADE-852E-4B9F23735816 Q37738261-DC7E11E0-0908-4126-B966-00A796DA396D Q37855227-8E0475DA-1CDE-4BBD-B083-7BCD4FB43838 Q39812610-ECE54395-DA92-4B2C-BAB9-17E7657572A8 Q41334556-581E4E45-119E-40F8-8D52-7228631481ED Q42513695-C5DC01AD-8E90-45F1-96B5-887573D39E87 Q44416876-BC036A64-4D1D-4CBA-A132-C5773421B49F Q44745420-A6136E24-217D-4D30-B219-7D1C39F4D3A1 Q45327318-6E58CF56-B152-4C05-92D3-4F8752B4F9B6 Q45859705-EBA09D93-BA99-4EFC-AEB3-5F0E67B926F3

P2860

MDM2 SNP309 accelerates colorectal tumour formation in women.

http://www.wikidata.org/entity/Q43146294

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

MDM2 SNP309 accelerates colorectal tumour formation in women.

@en

MDM2 SNP309 accelerates colorectal tumour formation in women.

@nl

type

label

MDM2 SNP309 accelerates colorectal tumour formation in women.

@en

MDM2 SNP309 accelerates colorectal tumour formation in women.

@nl

prefLabel

MDM2 SNP309 accelerates colorectal tumour formation in women.

@en

MDM2 SNP309 accelerates colorectal tumour formation in women.

@nl

P1433

Q43146294-F066C191-A7D0-4646-9007-88A36CA168C1

P1476

Q43146294-421B8BFC-496D-4F2F-91B4-B458D89EF36D

P2093

Q43146294-10AFE551-639D-4024-A201-7738515F9667

Q43146294-7E8669C4-3C40-4F9E-B242-BE29C96AB1B1

Q43146294-A9D334D8-FF51-4519-BA6B-48E6B50861EE

Q43146294-C25AB3D7-CC11-4E22-B2CB-564D47559952

Q43146294-EC290D32-B628-4F85-B3D1-91C3AFA052F3

P2860

Q43146294-0B987A23-0D90-43FF-A4A5-DC316A53A51F

Q43146294-2A4EE4A1-AF0E-4FE5-AF0E-EA3EF7EF0D43

Q43146294-619D23DB-34DF-4F22-BAB4-51A14B40210F

Q43146294-83650C7C-3299-483B-B8CF-5EC2D1E14410

Q43146294-8964305F-A509-4689-8201-06F125E91B70

Q43146294-A81020FD-9253-49ED-8411-155682F399E9

Q43146294-C2071767-6F8F-4BC2-B9BD-CE8D4736EE6D

Q43146294-C6F70272-5033-4F4C-9927-425E1CC38EBC

Q43146294-D076BA7A-35E9-487B-8F2C-0AD2361B11E5

P304

Q43146294-5FCF5F38-9A90-4908-9346-9C8E795F1C4C

P31

Q43146294-B9BE7EB5-82C0-4A9F-8C3E-F63966ECB72E

Q43146294-c25140af-ad0d-498e-8eff-1e70c086f868

P356

Q43146294-5045A4D2-9A26-4F71-AE0C-B6F21965FB1F

P407

Q43146294-43D28320-6971-4FD7-8F06-AA514717BCB3

P433

Q43146294-4D5CDD91-3D9C-4A23-B217-0A8DA9647A95

P478

Q43146294-4592C0B3-166C-4679-84BE-C412B9D8FDAF

P50

Q43146294-EC8AF813-D8DE-4CB2-97CE-CFA368134BE9

P577

Q43146294-D5D2DF09-2EFF-414F-A9A0-D6F5008C03A0

P5875

Q43146294-90FF0507-8926-463C-A6DF-0BC54C9952AF

P698

Q43146294-A6B65C2E-31BD-4E0C-98C1-FAA4C3931E33

P932

Q43146294-6504CB1B-4399-4771-B51A-8037887FCDC8

P356

JMG.2006.043539

P1433

Journal of Medical Genetics

P1476

MDM2 SNP309 accelerates colorectal tumour formation in women

@en

P2093

Arnold J Levine

http://www.w3.org/2001/XMLSchema#string

Gareth L Bond

http://www.w3.org/2001/XMLSchema#string

Lauri A Aaltonen

http://www.w3.org/2001/XMLSchema#string

Pia Alhopuro

http://www.w3.org/2001/XMLSchema#string

Roberta Bertorelle

http://www.w3.org/2001/XMLSchema#string

P2860

MDM2 is a central node in the p53 pathway: 12 years and counting.

Improving cancer therapy by non-genotoxic activation of p53.

The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC)

The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

The IARC TP53 database: new online mutation analysis and recommendations to users.

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population.

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

P304

950-952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JMG.2006.043539

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6960568

http://www.w3.org/2001/XMLSchema#string

P698

16825430

http://www.w3.org/2001/XMLSchema#string

P932

2563203

http://www.w3.org/2001/XMLSchema#string